Allergy Immunotherapy Market Share, Trends, Size, Major Players And Forecast To 2033 |LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics PLC, ALK-Abelló A/S, HAL Allergy B.V

Overview and Scope
Allergy immunotherapy refers to a type of therapy used to avoid allergic reactions to things like house dust mites, grass pollen, and bee venom. Immunotherapy includes giving the patient increasingly higher dosages of the chemical or allergen they are allergic to.

Sizing and Forecast
The allergy immunotherapy market size has grown rapidly in recent years. It will grow from $2.59 billion in 2023 to $2.86 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%.  The  growth in the historic period can be attributed to increasing incidence of allergic diseases, advancements in immunotherapy techniques, growing awareness among patients, government initiatives, improvements in research and development.

The allergy immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $4.43 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%.  The growth in the forecast period can be attributed to rising global allergy burden, healthcare policy support, increasing acceptance of immunotherapy, emerging markets and untapped regions, increasing healthcare expenditure. Major trends in the forecast period include advancements in treatment technology, increasing allergy prevalence, rise in patient awareness and education, telemedicine and remote monitoring, customized treatment plans.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Segmentation & Regional Insights
The allergy immunotherapy market covered in this report is segmented –
1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types
2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)
3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Top 5 Major Players:

• LETI Pharma,
• Stallergenes Greer International AG,
• Allergy Therapeutics PLC,
• ALK-Abelló A/S,
• HAL Allergy B.V

Europe was the largest region in the allergy immunotherapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

Major Driver Impacting Market Growth
The rising prevalence of allergic disorders is expected to propel the growth of the allergy immunotherapy market going forward. Allergic disorders refer to excessive immune responses to specific antigens. Immune responses that are inappropriately directed against intrinsic bodily parts (self) result in autoimmune diseases. Allergy immunotherapy is available to atopic people who have allergy disorders like IgE-mediated allergic rhinitis and allergic asthma brought on by inhaled allergens, including pollens and house dust mites (HDMs). For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, in 2021, in the USA, nearly one-third of adults aged 18 and up suffered from a seasonal allergy, skin condition, or food allergy. Overall, seasonal allergy was the most common of the three allergies, with approximately one-quarter (25.7%) of adults diagnosed, followed by eczema (7.3%) and food allergy (6.2%). Women were more likely than men to be allergic to all three allergens. Also, the prevalence of seasonal allergy diagnoses was 24.7% in adults aged 18–44, 27.9% in adults aged 45–64, 26.4% in adults aged 65–74, and 21.7% in adults aged 75 and up. Therefore, the rising prevalence of allergic disorders is driving the growth of the allergy immunotherapy market.

Key Industry Players
Major companies operating in the allergy immunotherapy market are adopting a strategic partnership approach to expand their capabilities. Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. In November 2022, Vimian Group AB, a Sweden-based veterinary company, entered into a partnership with Angany Inc., a Canada-based pharmaceutical company dedicated to allergy immunotherapy. With this partnership, Vimian Group AB aims to develop novel vaccines for allergy and atopic dermatitis in companion animals with proprietary eBioparticle-Potentiated Immunotherapy technology.

The allergy immunotherapy market report table of contents includes:
1. Executive Summary
2. Allergy Immunotherapy Market Characteristics
3. Allergy Immunotherapy Market Trends And Strategies
4. Allergy Immunotherapy Market – Macro Economic Scenario
5. Global Allergy Immunotherapy Market Size and Growth

…

31. Global Allergy Immunotherapy Market Competitive Benchmarking
32. Global Allergy Immunotherapy Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Allergy Immunotherapy Market
34. Allergy Immunotherapy Market Future Outlook and Potential Analysis
35. Appendix

List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

….

Table 74: LETI Pharma Financial Performance
Table 75: Stallergenes Greer International AG Financial Performance
Table 76: Allergy Therapeutics plc Financial Performance
Table 77: ALK-Abelló A/S Financial Performance
Table 78: HAL Allergy B.V. Financial Performance

Explore the trending research reports from TBRC:
https://topprnews.com/excitation-systems-market-size/
https://topprnews.com/geothermal-power-generation-market-growth/
https://topprnews.com/industrial-machine-vision-market-share/
https://goodprnews.com/excitation-systems-market-size/
https://goodprnews.com/geothermal-power-generation-market-growth/
https://goodprnews.com/industrial-machine-vision-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model